Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Stephen J. Schuster | Researchclopedia

Back to researchers

Stephen J. Schuster

Goethe University Frankfurt ORCID

803

Works

32,850

Citations

75

h-index

283

i10-index

Research Topics

Lymphoma Diagnosis and Treatment CAR-T cell therapy research Chronic Lymphocytic Leukemia Research

Affiliations

Northwestern University2009–2009

Goethe University Frankfurt2025–2025

Novartis (Switzerland)2017–2023

Fox Chase Cancer Center2015–2017

Beth Israel Deaconess Medical Center2016–2016

Top Works

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Stephen J. Schuster,Michael Bishop,et al.

20183,943 citations

Viral-associated cancers and disorders

Cutaneous lymphoproliferative disorders research

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

Stephen M. Ansell,Alexander M. Lesokhin,et al.

20143,524 citations

Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas

Stephen J. Schuster,Jakub Svoboda,et al.

20171,823 citations

Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

John C. Byrd,Jennifer R. Brown,et al.

20141,603 citations

PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma

Ajay K. Gopal,Brad S. Kahl,et al.

20141,054 citations

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study

Alexander M. Lesokhin,Stephen M. Ansell,et al.

20161,004 citations

Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study

Stephen J. Schuster,Constantine S. Tam,et al.

2021539 citations

Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial

Nathan Fowler,Michael Dickinson,et al.

2021502 citations

Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma

Michael R. Bishop,Michael Dickinson,et al.

2021500 citations